Literature DB >> 9431942

Evaluation of four DNA typing techniques in epidemiological investigations of bovine tuberculosis.

D Cousins1, S Williams, E Liébana, A Aranaz, A Bunschoten, J Van Embden, T Ellis.   

Abstract

DNA fingerprinting techniques were used to type 273 isolates of Mycobacterium bovis from Australia, Canada, the Republic of Ireland, and Iran. The results of restriction fragment length polymorphism (RFLP) analysis with DNA probes from IS6110, the direct repeat (DR), and the polymorphic GC-rich sequence (PGRS) were compared with those of a new PCR-based method called spacer oligonucleotide typing (spoligotyping) developed for the rapid typing of Mycobacterium tuberculosis (J. Kamerbeek et al., J. Clin. Microbiol. 35:907-914, 1997). Eighty-five percent of the isolates harbored a single copy of IS6110, and 81.5% of these carried IS6110 on the characteristic 1.9-kb restriction fragment. RFLP analysis with IS6110 identified 23 different types, RFLP analysis with the DR probe identified 35 types, RFLP analysis with the PGRS probe identified 77 types, and the spoligotyping method identified 35 types. By combining all results, 99 different strains could be identified. Isolate clusters were frequently associated within herds or were found between herds when epidemiological evidence confirmed animal movements. RFLP analysis with IS6110 was sufficiently sensitive for the typing of isolates with more than three copies of IS6110, but RFLP analysis with the PGRS probe was the most sensitive typing technique for strains with only a single copy of IS6110. Spoligotyping may have advantages for the rapid typing of M. bovis, but it needs to be made more sensitive.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9431942      PMCID: PMC124829     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Molecular cloning of a highly repeated DNA element from Mycobacterium tuberculosis and its use as an epidemiological tool.

Authors:  B C Ross; K Raios; K Jackson; B Dwyer
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

2.  Insertion element IS987 from Mycobacterium bovis BCG is located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains.

Authors:  P W Hermans; D van Soolingen; E M Bik; P E de Haas; J W Dale; J D van Embden
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

Review 3.  A century of bovine tuberculosis 1888-1988: conquest and controversy.

Authors:  D G Pritchard
Journal:  J Comp Pathol       Date:  1988-11       Impact factor: 1.311

4.  Chromosomal DNA fingerprint patterns produced with IS6110 as strain-specific markers for epidemiologic study of tuberculosis.

Authors:  G H Mazurek; M D Cave; K D Eisenach; R J Wallace; J H Bates; J T Crawford
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

5.  Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis.

Authors:  D van Soolingen; P W Hermans; P E de Haas; D R Soll; J D van Embden
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

6.  Restriction fragment length polymorphism analysis using IS6110 as an epidemiological marker in tuberculosis.

Authors:  I Otal; C Martín; V Vincent-Lévy-Frebault; D Thierry; B Gicquel
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

7.  Use of DNA restriction fragment typing in the differentiation of Mycobacterium tuberculosis complex isolates from animals and humans in Burundi.

Authors:  L Rigouts; B Maregeya; H Traore; J P Collart; K Fissette; F Portaels
Journal:  Tuber Lung Dis       Date:  1996-06

8.  An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

Authors:  C L Daley; P M Small; G F Schecter; G K Schoolnik; R A McAdam; W R Jacobs; P C Hopewell
Journal:  N Engl J Med       Date:  1992-01-23       Impact factor: 91.245

9.  Survival of Mycobacterium bovis in defined environmental conditions.

Authors:  B J Duffield; D A Young
Journal:  Vet Microbiol       Date:  1985-01       Impact factor: 3.293

10.  Transmission of tuberculosis from experimentally infected cattle to in-contact calves.

Authors:  S D Neill; J Hanna; J J O'Brien; R M McCracken
Journal:  Vet Rec       Date:  1989-03-18       Impact factor: 2.695

View more
  36 in total

Review 1.  Genetic fingerprinting in the study of tuberculosis transmission.

Authors:  S Kulaga; M A Behr; K Schwartzman
Journal:  CMAJ       Date:  1999-11-02       Impact factor: 8.262

2.  Study of restriction fragment length polymorphism analysis and spoligotyping for epidemiological investigation of Mycobacterium bovis infection.

Authors:  E Costello; D O'Grady; O Flynn; R O'Brien; M Rogers; F Quigley; J Egan; J Griffin
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

3.  Different strategies for molecular differentiation of Mycobacterium bovis strains isolated in Sardinia, Italy.

Authors:  L A Sechi; G Leori; S A Lollai; I Duprè; P Molicotti; G Fadda; S Zanetti
Journal:  Appl Environ Microbiol       Date:  1999-04       Impact factor: 4.792

4.  Characterization of Mycobacterium tuberculosis isolates from patients in Houston, Texas, by spoligotyping.

Authors:  H Soini; X Pan; A Amin; E A Graviss; A Siddiqui; J M Musser
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

5.  Usefulness of mycobacterial interspersed repetitive-unit locus PCR amplification in rapid diagnosis of Beijing lineage strain infection among pediatric tuberculosis patients.

Authors:  Ruixi Liu; Linlin Xing; Ze Peng; Yukun Zhang; Chaomin Zhu; Zhenhua Yang
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

6.  Rapid identification of Mycobacterium tuberculosis Beijing genotypes on the basis of the mycobacterial interspersed repetitive unit locus 26 signature.

Authors:  K Rajender Rao; Niyaz Ahmed; Sriramula Srinivas; Leonardo A Sechi; Seyed E Hasnain
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

7.  Spoligotyping of Mycobacterium bovis isolates found in Manitoba.

Authors:  Cyril Lutze-Wallace; Claude Turcotte; Melanie Sabourin; Gloria Berlie-Surujballi; Yvon Barbeau; Dianne Watchorn; John Bell
Journal:  Can J Vet Res       Date:  2005-04       Impact factor: 1.310

8.  African 2, a clonal complex of Mycobacterium bovis epidemiologically important in East Africa.

Authors:  Stefan Berg; M Carmen Garcia-Pelayo; Borna Müller; Elena Hailu; Benon Asiimwe; Kristin Kremer; James Dale; M Beatrice Boniotti; Sabrina Rodriguez; Markus Hilty; Leen Rigouts; Rebuma Firdessa; Adelina Machado; Custodia Mucavele; Bongo Nare Richard Ngandolo; Judith Bruchfeld; Laura Boschiroli; Annélle Müller; Naima Sahraoui; Maria Pacciarini; Simeon Cadmus; Moses Joloba; Dick van Soolingen; Anita L Michel; Berit Djønne; Alicia Aranaz; Jakob Zinsstag; Paul van Helden; Françoise Portaels; Rudovick Kazwala; Gunilla Källenius; R Glyn Hewinson; Abraham Aseffa; Stephen V Gordon; Noel H Smith
Journal:  J Bacteriol       Date:  2010-11-19       Impact factor: 3.490

9.  Molecular typing of Mycobacterium bovis strains isolated in Italy from 2000 to 2006 and evaluation of variable-number tandem repeats for geographically optimized genotyping.

Authors:  M Beatrice Boniotti; Maria Goria; Daniela Loda; Annalisa Garrone; Alessandro Benedetto; Alessandra Mondo; Ernesto Tisato; Mariagrazia Zanoni; Simona Zoppi; Alessandro Dondo; Silvia Tagliabue; Stefano Bonora; Giorgio Zanardi; M Lodovica Pacciarini
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

10.  Mycobacterium bovis subsp. caprae caused one-third of human M. bovis-associated tuberculosis cases reported in Germany between 1999 and 2001.

Authors:  Tanja Kubica; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.